MANILA – The Department of Justice (DOJ) and the Dangerous Drugs Board (DDB) have launched an executive review of Republic Act 9165, or the Dangerous Drugs Act of 2002, as amended, in line with President Ferdinand R. Marcos Jr.’s directive to tackle the country’s drug problem through a balanced and comprehensive approach.

The review aims to address drug-related issues by focusing on both enforcement and rehabilitation, promoting a “whole-of-government approach” that integrates law enforcement with social services and community-based interventions. This includes rehabilitation, education, and reintegration programs for drug offenders.

DOJ Undersecretary Jesse Hermogenes Andres and DDB Secretary Oscar Valenzuela represented their agencies at the first Pre-Writeshop Activity held on Feb. 11.

The review involves input from non-government organizations, civil society groups, the University of the Philippines’ Institute of Human Rights, and international partners such as the United Nations Office on Drugs and Crimes (UNODC).

According to Andres, the process will be highly consultative, ensuring that feedback from relevant stakeholders, including those voiced during the 1st Drug Policy and Law Reform Summit in July 2024, is carefully considered. Input from human rights and health advocates will also be taken into account.

The DOJ and DDB stated that the review’s findings would be used to draft proposed amendments to RA 9165. These changes will be evidence-based, backed by studies and data, and aligned with international standards and best practices.